{
    "organizations": [],
    "uuid": "94907f8764801ddecd88a3b9ea75a86d70d0e678",
    "author": "",
    "url": "https://www.reuters.com/article/brief-edge-therapeutics-provides-update/brief-edge-therapeutics-provides-update-following-interim-analysis-idUSASC09TXI",
    "ord_in_thread": 0,
    "title": "BRIEF-Edge Therapeutics Provides Update Following Interim Analysis",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 30 AM / Updated 16 minutes ago BRIEF-Edge Therapeutics Provides Update Following Interim Analysis Reuters Staff 1 Min Read \nMarch 28 (Reuters) - Edge Therapeutics Inc: \n* EDGE THERAPEUTICS PROVIDES UPDATE FOLLOWING INTERIM ANALYSIS OF PHASE 3 NEWTON 2 STUDY OF EG-1962 IN ANEURYSMAL SUBARACHNOID HEMORRHAGE \n* EDGE THERAPEUTICS INC - STUDY UNLIKELY TO ACHIEVE PRIMARY EFFICACY ENDPOINT; DMC RECOMMENDS DISCONTINUATION OF STUDY \n* EDGE THERAPEUTICS INC - NO UNEXPECTED SAFETY FINDINGS IN STUDY \n* EDGE THERAPEUTICS INC - EDGE TO REDUCE COSTS AND EVALUATE NEXT STEPS \n* EDGE THERAPEUTICS - PHASE 3 STUDY OF EG-1962 SHOWED LOW PROBABILITY OF ACHIEVING STATISTICALLY-SIGNIFICANT DIFFERENCE VERSUS STANDARD OF CARE \n* EDGE THERAPEUTICS - DATA MONITORING COMMITTEE RECOMMENDED STUDY BE STOPPED BASED ON CONCLUSION THAT STUDY HAS LOW PROBABILITY OF MEETING PRIMARY ENDPOINT \n* EDGE THERAPEUTICS - ANTICIPATES IN NEAR TERM REDUCING SCOPE OF OPERATIONS, INCLUDING SIZE OF WORKFORCE, IN ORDER TO PRESERVE CASH RESOURCES \n* EDGE THERAPEUTICS INC - HAS DECIDED TO DISCONTINUE NEWTON 2 STUDY Source text for Eikon: Further company coverage:",
    "published": "2018-03-28T14:30:00.000+03:00",
    "crawled": "2018-03-28T14:54:08.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "provides",
        "update",
        "following",
        "interim",
        "analysis",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "edge",
        "therapeutic",
        "inc",
        "edge",
        "therapeutic",
        "provides",
        "update",
        "following",
        "interim",
        "analysis",
        "phase",
        "newton",
        "study",
        "aneurysmal",
        "subarachnoid",
        "hemorrhage",
        "edge",
        "therapeutic",
        "inc",
        "study",
        "unlikely",
        "achieve",
        "primary",
        "efficacy",
        "endpoint",
        "dmc",
        "recommends",
        "discontinuation",
        "study",
        "edge",
        "therapeutic",
        "inc",
        "unexpected",
        "safety",
        "finding",
        "study",
        "edge",
        "therapeutic",
        "inc",
        "edge",
        "reduce",
        "cost",
        "evaluate",
        "next",
        "step",
        "edge",
        "therapeutic",
        "phase",
        "study",
        "showed",
        "low",
        "probability",
        "achieving",
        "difference",
        "versus",
        "standard",
        "care",
        "edge",
        "therapeutic",
        "data",
        "monitoring",
        "committee",
        "recommended",
        "study",
        "stopped",
        "based",
        "conclusion",
        "study",
        "low",
        "probability",
        "meeting",
        "primary",
        "endpoint",
        "edge",
        "therapeutic",
        "anticipates",
        "near",
        "term",
        "reducing",
        "scope",
        "operation",
        "including",
        "size",
        "workforce",
        "order",
        "preserve",
        "cash",
        "resource",
        "edge",
        "therapeutic",
        "inc",
        "decided",
        "discontinue",
        "newton",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}